| Primary |
| Product Used For Unknown Indication |
19.7% |
| Blood Cholesterol Increased |
11.8% |
| Diarrhoea |
9.2% |
| Hyperlipidaemia |
7.9% |
| Hypertension |
7.9% |
| Irritable Bowel Syndrome |
5.3% |
| Prophylaxis |
5.3% |
| Diabetes Mellitus |
3.9% |
| Essential Tremor |
3.9% |
| Malabsorption |
3.9% |
| Pruritus |
3.9% |
| Congenital Absence Of Bile Ducts |
2.6% |
| Hepatitis Neonatal |
2.6% |
| Hypercholesterolaemia |
2.6% |
| Upper Gastrointestinal Haemorrhage |
2.6% |
| Androgen Deficiency |
1.3% |
| Blood Cholesterol Abnormal |
1.3% |
| Crohn's Disease |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Faecal Incontinence |
1.3% |
|
| Rash |
8.8% |
| Adverse Event |
5.9% |
| Drug Ineffective |
5.9% |
| Drug Intolerance |
5.9% |
| Hyperglycaemia |
5.9% |
| Intestinal Obstruction |
5.9% |
| Nausea |
5.9% |
| Product Quality Issue |
5.9% |
| Rectal Haemorrhage |
5.9% |
| Urticaria |
5.9% |
| Vitamin K Deficiency |
5.9% |
| Vomiting |
5.9% |
| Weight Decreased |
5.9% |
| Abdominal Discomfort |
2.9% |
| Abdominal Pain |
2.9% |
| Abdominal Pain Upper |
2.9% |
| Blood Glucose Fluctuation |
2.9% |
| Blood Phosphorus Increased |
2.9% |
| Constipation |
2.9% |
| Death |
2.9% |
|
| Secondary |
| Crohn's Disease |
36.5% |
| Product Used For Unknown Indication |
27.0% |
| Drug Use For Unknown Indication |
7.6% |
| Hypercholesterolaemia |
6.6% |
| Diarrhoea |
3.8% |
| Choriocarcinoma |
2.4% |
| Osteoporosis |
2.4% |
| Hypertension |
1.9% |
| Thyrotoxic Crisis |
1.9% |
| Type Iia Hyperlipidaemia |
1.9% |
| Blood Cholesterol Increased |
1.4% |
| Essential Tremor |
1.4% |
| Juvenile Arthritis |
0.9% |
| Pruritus |
0.9% |
| Therapeutic Procedure |
0.9% |
| Androgen Deficiency |
0.5% |
| Benign Prostatic Hyperplasia |
0.5% |
| Blood Cholesterol |
0.5% |
| Blood Pressure Increased |
0.5% |
| Cholestasis |
0.5% |
|
| Completed Suicide |
22.0% |
| Crohn's Disease |
9.8% |
| Vitamin K Deficiency |
9.8% |
| Death |
7.3% |
| Polyp |
7.3% |
| Hypomagnesaemia |
4.9% |
| Pyrexia |
4.9% |
| Toxicity To Various Agents |
4.9% |
| Abdominal Pain Upper |
2.4% |
| Adverse Drug Reaction |
2.4% |
| Dehydration |
2.4% |
| Drug Exposure During Pregnancy |
2.4% |
| Ejection Fraction Decreased |
2.4% |
| Gait Disturbance |
2.4% |
| Hypokalaemia |
2.4% |
| Hypovolaemia |
2.4% |
| Incision Site Infection |
2.4% |
| Intestinal Obstruction |
2.4% |
| Melaena |
2.4% |
| Muscle Spasms |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.5% |
| Crohn's Disease |
15.8% |
| Drug Use For Unknown Indication |
10.7% |
| Hypertension |
3.9% |
| Pain |
3.8% |
| Diarrhoea |
3.5% |
| Depression |
2.7% |
| Vitamin Supplementation |
2.0% |
| Rheumatoid Arthritis |
1.9% |
| Premedication |
1.9% |
| Nausea |
1.8% |
| Osteoporosis |
1.8% |
| Blood Cholesterol Increased |
1.7% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hepatitis C |
1.4% |
| Contraception |
1.3% |
| Migraine |
1.3% |
| Mineral Supplementation |
1.3% |
| Anxiety |
1.2% |
| Diabetes Mellitus |
1.1% |
|
| Vomiting |
13.0% |
| Weight Decreased |
9.5% |
| Pain |
6.1% |
| Diarrhoea |
5.6% |
| Fatigue |
5.6% |
| Injection Site Pain |
5.6% |
| Nausea |
5.2% |
| Pain In Extremity |
5.2% |
| Weight Increased |
5.2% |
| Flushing |
4.3% |
| Urticaria |
4.3% |
| Crohn's Disease |
3.9% |
| Death |
3.5% |
| Myocardial Infarction |
3.5% |
| Renal Failure Acute |
3.5% |
| Tremor |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Drug Ineffective |
3.0% |
| Myalgia |
3.0% |
| Pneumonia |
3.0% |
|
| Interacting |
| Gastric Haemorrhage |
38.9% |
| Constipation |
22.2% |
| Pruritus |
22.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
11.1% |
| Pancreatic Fistula |
5.6% |
|
| Drug Interaction |
40.0% |
| Therapeutic Procedure |
40.0% |
| Respiratory Distress |
20.0% |
|
